 NEW YORK, March 04, 2022 GLOBE NEWSWIRE -- IO Biotech Nasdaq: IOBT, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win technology platform, announced today it will present at the 42nd Annual Cowen Health Care Conference to be held virtually March 7 9, 2022. At the conference, IO Biotech CEO Dr. Mai-Britt Zocca will participate in the Novel IO Panel Discussion. 